Skip to content
value.today

Arbor Pharmaceuticals Inc.

🇺🇸 Raleigh, North Carolina, USAPharmaceuticalsFounded 2006
Total raised
$22 M
2 rounds on record
Latest round
$17 M
Nov 2010
First round on record
Apr 2010
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Arbor Pharmaceuticals Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2010$17 MNo. 2$10 to $50 million

Arbor Pharmaceuticals Inc.: Raise no. 2, Nov 2010

Investors in this round

10 investors had bought by the notice of Dec 10, 2010: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $17 M offered
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Edward Schutter · Executive Officer, Director
  • Jarrett Disbrow · Executive Officer
  • Jason Wild · Executive Officer, Director
  • John Donofrio · Executive Officer
  • Joshua Disbrow · Executive Officer
  • Allen Chao · Director
  • Marianne Boskamp · Director
  • Michael Fedida · Director
  • Todd Sone · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Edward Schutter, President & CEO. Source: SEC Form D, newest notice filed Dec 10, 2010. Read the notice at the SEC.

equitySEC
Apr 2010$5 MNo. 1$2 to $10 million

Arbor Pharmaceuticals Inc.: Raise no. 1, Apr 2010

Investors in this round

7 investors had bought by the notice of Apr 20, 2010: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$25,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Edward Schutter · Executive Officer, Director
  • Jarrett Disbrow · Executive Officer
  • Jason Wild · Executive Officer, Director
  • Allen Chao · Director
  • Michael Fedida · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Edward Schutter, President & CEO. Source: SEC Form D, newest notice filed Apr 20, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Arbor Pharmaceuticals Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2010).

    SEC Form D · Dec 2010

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Dec 2010

That is all the official record says: Arbor Pharmaceuticals Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Arbor Pharmaceuticals Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 10 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Arbor Pharmaceuticals Inc.
NameRoleNamed in
Edward SchutterExecutive officerDec 2010
Jarrett DisbrowExecutive officerDec 2010
Jason WildExecutive officerDec 2010
John DonofrioExecutive officerDec 2010
Joshua DisbrowExecutive officerDec 2010
Allen ChaoDirectorDec 2010
Edward SchutterDirectorDec 2010
Jason WildDirectorDec 2010
Marianne BoskampDirectorDec 2010
Michael FedidaDirectorDec 2010
Todd SoneDirectorDec 2010